Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Year: 2021, Chapter: 285